Anti-Influenza B Antibody, Core, clone 22D5-12-13

Epitope: Core

Indirect Immunofluorescence

Optimal dilutions must be determined by end user.

Research Category
Infectious Diseases

Research Sub Category
Infectious Diseases - Viral

This Anti-Influenza B Antibody, Core, clone 22D5-12-13 is validated for use in IF for the detection of Influenza B.

Recognizes Influenza B, anti-core specific; reacts with all strains of Influenza B tested. No reactivity with Flu A or other respiratory viruses.

Format: Purified

Protein A Purified. Liquid in 0.02M phosphate buffer, 0.25M sodium chloride, pH 7.6 with 0.1% sodium azide

Protein A purified

Maintain for 1 year at 2–8°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Control
Influenza Control Slides, Catalogue Number 5010-5

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.